CanProtect – Canadian Recommendations and Strategies for Protecting Your Patients Against Herpes Zoster and COVID-19 – Why some Patients Die and an Update on COVID Vaccines
Peter Lin, MD, CCFP
Topics: COVID-19, Herpes Zoster, Vaccines
Details
Objectives
- Describe the burden of disease associated with herpes zoster (HZ) and need for improved adult immunization rates
- Discuss clinical evidence available for HZ vaccines in Canada and current National Advisory Committee on Immunization (NACI) recommendations
- Evaluate best practices for applying recommendations to practice and strategies for optimizing adult immunization for HZ
- Review why some Patients are Asymptomatic and Other Dies
- Review the Current Status of Covid-19 Vaccines.
Faculty
Peter Lin MD, CCFP
Dr. Peter Lin began his studies in the Faculty of Science and Engineering at the University of Toronto in Toronto, Ontario. Midway through, he moved to the Faculty of Medicine, where he completed his studies and became involved in research. Over the years, it became apparent to him that there was a wide chasm between research and clinical practice, and he moved into clinical practice in primary care and eventually into teaching in order to help bridge this gap. He served as the medical director at the Health & Wellness Centre, University of Toronto Scarborough, for 7 years. Currently, he is the Director of Primary Care Initiatives at the Canadian Heart Research Centre. He lectures and speaks throughout the world and maintains two busy family practices in Toronto.